INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV)

CUSIP: 45409B412

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / IQ S&P HGH YLD
Total 13F shares
3,458,168
Share change
+67,533
Total reported value
$80,507,000
Price per share
$23.32
Number of holders
15
Value change
+$1,558,414
Number of buys
4
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 45409B412?
CUSIP 45409B412 identifies HYLV - INDEXIQ ETF TR - IQ S&P HGH YLD in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) as of Q4 2018

As of 31 Dec 2018, INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,458,168 shares. The largest 10 holders included MACKAY SHIELDS LLC, NEW YORK LIFE INVESTMENT MANAGEMENT LLC, JANE STREET GROUP, LLC, RAYMOND JAMES & ASSOCIATES, CITADEL ADVISORS LLC, LPL Financial LLC, USAdvisors Wealth Management, LLC, ROYAL BANK OF CANADA, UBS Group AG, and IFP Advisors, Inc. This page lists 15 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.